EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
1.14.11.29 | Acute Kidney Injury |
22262480 |
Pre-ischemic Targeting of HIF Prolyl Hydroxylation Inhibits Fibrosis associated with Acute Kidney Injury. |
therapeutic application unassigned |
2 0 |
1.14.11.29 | Adenocarcinoma |
9818031 |
Induction of apoptosis in human pancreatic carcinoma cells by a synthetic bleomycin-like ligand. |
causal interaction ongoing research unassigned |
3 2 0 |
1.14.11.29 | Adenocarcinoma of Lung |
30575913 |
Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma. |
causal interaction diagnostic usage ongoing research unassigned |
1 2 4 0 |
1.14.11.29 | Adenocarcinoma of Lung |
33823854 |
An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma. |
causal interaction therapeutic application unassigned |
2 4 0 |
1.14.11.29 | Adenoma, Oxyphilic |
18773095 |
Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated ELGN2-mediated oxygen-sensing response. |
unassigned |
0 |
1.14.11.29 | Altitude Sickness |
22595196 |
EPAS1 and EGLN1 associations with high altitude sickness in Han and Tibetan Chinese at the Qinghai-Tibetan Plateau. |
diagnostic usage ongoing research unassigned |
2 2 0 |
1.14.11.29 | Altitude Sickness |
25431923 |
Variants of the low oxygen sensors EGLN1 and HIF-1AN associated with acute mountain sickness. |
unassigned |
0 |
1.14.11.29 | Altitude Sickness |
31555147 |
Population History and Altitude-Related Adaptation in the Sherpa. |
unassigned |
0 |
1.14.11.29 | Anemia |
20185832 |
Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury. |
causal interaction ongoing research therapeutic application unassigned |
3 4 3 0 |
1.14.11.29 | Anemia |
20432181 |
American chemical society - 239th national meeting - investigating new therapeutic candidates: part 2. |
causal interaction therapeutic application unassigned |
1 4 0 |